Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Lung Cancer Management is Scopus-indexed (Q3, CiteScore 2.2), WoS ESCI. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 1758-1966Verify ISSN ↗1758-1974Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 100 / 165 | 39th | Q3 |
| Oncology | 287 / 428 | 33rd | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present (also 2014), best quartile Q3, CiteScore 2.2.
Lung Cancer Management is Q3 in Pulmonary and Respiratory Medicine (rank 100 of 165) and Q3 in Oncology (rank 287 of 428), by CiteScore 2025.
Lung Cancer Management is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.2, which places it in quartile Q3 at the 39th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.468, quartile Q3, with an H-index of 9.
Lung Cancer Management is published by Taylor and Francis Ltd. Its print ISSN is 1758-1966 and its online ISSN is 1758-1974.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Lung Cancer Management has an h-index of 19 and a 2-year mean of 1.17 citations per paper (OpenAlex). Its Scopus CiteScore is 2.2, quartile Q3. On 2-year citations it ranks #90 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Lung Cancer Management published 5 papers in 2025; its busiest recent year was 2020 with 23. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 40 research articles (2021–2026), authors are most often from China (24.9%), United States (24.4%) and Japan (7.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.